Lupus nephritis in Puerto Rican children and adolescents

Tami O Tiamfook1, Ivonne Arroyo, Enid Del Valle

  • 1Harvard Medical School, Boston, MA, USA.

Insights

Lupus nephritis in Puerto Rican children often presents as Type II glomerulonephritis. However, Type IV nephritis and the need for dialysis predict poor outcomes in pediatric lupus nephritis patients.

Area of Science:

  • Pediatric Nephrology
  • Rheumatology
  • Immunology

Background:

  • Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE).
  • Pediatric LN carries a significant risk for poor patient and renal survival.
  • Clinical manifestations of LN in Puerto Rican children may differ from other populations, potentially due to environmental factors like sun exposure.

Purpose of the Study:

  • To characterize the clinical and histopathological features of lupus nephritis in children in Puerto Rico.
  • To identify predictors of patient and renal survival in this pediatric cohort.

Main Methods:

  • Retrospective review of medical charts of children diagnosed with lupus nephritis between 1987 and 2001 in Puerto Rico.
  • Analysis of histopathological findings and clinical outcomes.

Main Results:

  • Mesangial glomerulonephritis (Class II) was the most frequent histopathological finding.
  • A higher incidence of nephritis was observed in males (male:female ratio of 1:1.9).

Conclusions:

  • Histopathological evidence of Class IV nephritis and the requirement for acute dialysis at presentation are significant predictors of poor clinical outcomes, including end-stage renal disease (ESRD) or death.
  • These findings highlight the importance of early identification and aggressive management of severe lupus nephritis in pediatric patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...